Osteoporosis Drug FDA Approved To Prevent New Fractures
July 10, 2008 | New York, New York | Vetting explained
The U.S. Food and Drug Administration (FDA) has approved a new once-a-month dose of Actonel, making it the only oral once-a-month osteoporosis therapy approved to help prevent both spinal and non-spinal fractures in postmenopausal women.
The new once-a-month dose is now available for patients seeking the fracture protection of Actonel in the convenience of one monthly pill. In addition to being approved to help protect the spine from fractures, Actonel is also approved to help prevent non-spinal fractures, measured as a group, namely the hip, wrist, collar bone, arm, pelvis, and leg.
- Tags:
- health,
- fitness,
- osteoporosis,
- actonel,
- drugs,
- fractures,
- women,
- post,
- menopausel
- Posted in Assignment:
- Keeping healthy, keeping fit
iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.
What is iReport?
-
Share
Tell a story, offer an opinion, say what's important to you.
-
Discuss
Join the conversation on the day's big issues.
-
Be heard
The best iReports get vetted and used on CNN platforms.
The label “Not vetted by CNN” lets you know that this story hasn’t been both checked and cleared by a CNN editor.
iReport stories that have a red "CNN iReport" stamp in the corner have been vetted and
cleared. That means they've been selected and approved by a CNN producer to use on CNN,
on air, or on any of CNN's platforms.





Comments